Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Merck & Co. fibrinogen antagonist characterized in animals

June 9, 1997

Fibrinogen antagonists from Merck & Co.

June 6, 1997

First launch for lepirudin

June 5, 1997

Orally active antiplatelet agents described by Taisho

June 3, 1997

Astra shifts focus to newer thrombin inhibitor

June 2, 1997

Wyeth-Ayerst's Normiflo approved for prevention of deep vein thrombosis

June 2, 1997

Nissan Chem. reveals antiplatelet agents

May 29, 1997

Neutralase effective for heparin reversal in CAB

May 27, 1997

Texas Biotechnology reports phase III results with Novastan in HIT and HITTS

May 23, 1997

Molecumetics and Asahi enter anticoagulant collaboration

May 22, 1997

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...